Verrica Pharmaceuticals Inc. (VRCA)

USD 0.64

(-8.13%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 5.12 Million 9.03 Million 12 Million - - -
Cost of Revenue 746 Thousand 725 Thousand 472 Thousand 229 Thousand 257.19 Thousand 20.29 Thousand
Gross Profit 4.37 Million 8.3 Million 11.52 Million -229 Thousand -257.19 Thousand -20.29 Thousand
Operating Expenses 70.59 Million 29.6 Million 42.9 Million 40.18 Million 30.08 Million 21.87 Million
Selling, General and Administrative Expenses 47.3 Million 17.4 Million 26.97 Million 24.5 Million 14.64 Million 9.05 Million
Research and Development Expenses 20.29 Million 12.19 Million 15.92 Million 15.67 Million 15.43 Million 12.82 Million
Other Expenses 2.53 Million -58 Thousand - -1000.00 1.87 Million -1000.00
Cost and Expenses 70.88 Million 30.32 Million 42.9 Million 40.18 Million 30.08 Million 21.87 Million
Operating Income -65.75 Million -21.29 Million -30.9 Million -40.18 Million -30.08 Million -21.87 Million
Interest Expense 3.96 Million 2.17 Million 4.29 Million 3.03 Million - -
Income Tax Expense - 3.19 Million 3.82 Million 2.8 Million -257 Thousand 1.23 Million
Earnings before Tax -66.99 Million -24.48 Million -35.08 Million -42.69 Million -28.2 Million -20.64 Million
Net Income -66.99 Million -27.67 Million -38.9 Million -45.49 Million -27.95 Million -20.64 Million
Earnings Per Share Basic -1.48 -0.81 -1.44 -1.82 -1.12 -1.41
Earnings Per Share Diluted -1.48 -0.81 -1.44 -1.82 -1.12 -1.41
Weighted Average Shares Outstanding 45.34 Million 34.16 Million 27.04 Million 24.99 Million 24.89 Million 14.66 Million
Weighted Average Shares Outstanding (Diluted) 45.34 Million 34.16 Million 27.04 Million 24.99 Million 24.89 Million 14.66 Million
Gross Margin 0.85 0.92 0.96 - - -
EBIT Margin -12.14 -2.31 -2.57 - - -
Profit Margin -13.07 -3.06 -3.24 - - -
EBITDA -62.19 Million -21.59 Million -30.31 Million -39.43 Million -30.08 Million -20.62 Million
Earnings Before Tax Margin -12.83 -2.36 -2.58 - - -

Income Statement Charts